Search results
Sir Gregory Paul Winter CBE FRS FMedSci (born 14 April 1951) is a Nobel Prize-winning English molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering , in Cambridge, England.
May 10, 2024 · Sir Gregory Paul Winter. Born: April 14, 1951, Leicester, England (age 73) Founder: Cambridge Antibody Technology. Domantis. Awards And Honors: Nobel Prize (2018) Subjects Of Study: adalimumab. antibody. bacteriophage. breast cancer. cancer.
- Kara Rogers
Oct 3, 2018 · Sir Greg Winter, of the University of Cambridge, has been jointly awarded the 2018 Nobel Prize in Chemistry, along with Frances Arnold and George Smith, for his pioneering work in using phage display for the directed evolution of antibodies, with the aim of producing new pharmaceuticals.
Sir Gregory P. Winter. The Nobel Prize in Chemistry 2018. Born: 14 April 1951, Leicester, United Kingdom. Affiliation at the time of the award: MRC Laboratory of Molecular Biology, Cambridge, United Kingdom. Prize motivation: “for the phage display of peptides and antibodies” Prize share: 1/4. Life.
I also developed genetic engineering strategies for the design (1984–1988) and evolution (1988– 1997) of antibody pharmaceuticals suitable for treatment of cancer and immune disorders, helping to spearhead the development of antibodies as a new class of powerful biologics.
People also ask
Who is Gregory Winter?
How did Gregory Winter use phage display?
When did Gregory Winter demonstrate two methods for pipetting small volumes?
Interview with Chemistry Laureate Sir Gregory P. Winter on 6 December 2018 during the Nobel Week in Stockholm, Sweden. Read the interview. Sir Gregory P. Winter answers the following questions (the links below lead to clip on YouTube): 00:09 – When did you decide that you wanted to become a scientist?
Sir Gregory Winter CBE FMedSci FRS. Gregory Winter is a molecular biologist who has pioneered the field of protein engineering and played an important role in sequencing the genome of the influenza virus. The techniques he invented in the 1980s for the industrial production of human antibodies for therapeutic purposes remain in widespread use.
